1. Home
  2. BCAB vs SGRP Comparison

BCAB vs SGRP Comparison

Compare BCAB & SGRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • SGRP
  • Stock Information
  • Founded
  • BCAB 2007
  • SGRP 1967
  • Country
  • BCAB United States
  • SGRP United States
  • Employees
  • BCAB N/A
  • SGRP N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • SGRP Business Services
  • Sector
  • BCAB Health Care
  • SGRP Consumer Discretionary
  • Exchange
  • BCAB Nasdaq
  • SGRP Nasdaq
  • Market Cap
  • BCAB 31.5M
  • SGRP 27.0M
  • IPO Year
  • BCAB 2020
  • SGRP 1996
  • Fundamental
  • Price
  • BCAB $0.79
  • SGRP $1.06
  • Analyst Decision
  • BCAB Hold
  • SGRP
  • Analyst Count
  • BCAB 3
  • SGRP 0
  • Target Price
  • BCAB $1.00
  • SGRP N/A
  • AVG Volume (30 Days)
  • BCAB 953.7K
  • SGRP 49.9K
  • Earning Date
  • BCAB 11-06-2025
  • SGRP 11-13-2025
  • Dividend Yield
  • BCAB N/A
  • SGRP N/A
  • EPS Growth
  • BCAB N/A
  • SGRP N/A
  • EPS
  • BCAB N/A
  • SGRP N/A
  • Revenue
  • BCAB $11,000,000.00
  • SGRP $143,501,000.00
  • Revenue This Year
  • BCAB N/A
  • SGRP $7.22
  • Revenue Next Year
  • BCAB N/A
  • SGRP N/A
  • P/E Ratio
  • BCAB N/A
  • SGRP N/A
  • Revenue Growth
  • BCAB N/A
  • SGRP N/A
  • 52 Week Low
  • BCAB $0.24
  • SGRP $0.91
  • 52 Week High
  • BCAB $2.53
  • SGRP $2.48
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 66.59
  • SGRP 42.94
  • Support Level
  • BCAB $0.63
  • SGRP $0.99
  • Resistance Level
  • BCAB $0.89
  • SGRP $1.09
  • Average True Range (ATR)
  • BCAB 0.07
  • SGRP 0.05
  • MACD
  • BCAB 0.00
  • SGRP -0.01
  • Stochastic Oscillator
  • BCAB 70.47
  • SGRP 38.72

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About SGRP SPAR Group Inc.

SPAR Group Inc is a merchandising and brand marketing services company, providing a broad range of sales-enhancing services to retailers across classes of trade and consumer goods manufacturers and distributors. It also provides a range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from the Americas.

Share on Social Networks: